Intraperitoneal chemotherapy: introduction of a new "single use" delivery system--a preliminary report.
Intraperitoneal administration of chemotherapy in ovarian cancer is currently under investigation. In this preliminary report we introduce the "Veress-needle" as a "single-use" delivery system of intraperitoneal chemotherapy. A total of 22 infusions in 7 patients revealed no major complications, and during 4 infusions only minor side effects were noted. The technique described seems to fulfill the need for a safe, reliable, and acceptable delivery system of intraperitoneal chemotherapy.
Pfeiffer
P
P
Department of Oncology, Odense University Hospital, Denmark.
Asmussen
L
L
Kvist-Poulsen
H
H
Bertelsen
K
K
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin